Filter
426
Text search:
drug
import
Featured
Recommendations
27
New Publications
123
Language
Document type
No document type
232
Studies & Reports
81
Guidelines
68
Manuals
17
Strategic & Response Plan
16
Training Material
4
Situation Updates
3
Fact sheets
3
Resource Platforms
2
Countries / Regions
India
24
Global
15
South Africa
14
Uganda
12
Nepal
12
Western and Central Europe
12
Sierra Leone
11
Kenya
11
Liberia
10
Nigeria
10
Tanzania
9
Ghana
8
Zimbabwe
8
South–East Asia Region
8
Ethiopia
7
Zambia
7
Rwanda
7
Bangladesh
7
Malawi
6
Ukraine
5
Myanmar / Burma
5
Venezuela
5
Burkina Faso
4
Senegal
4
Syria
4
Indonesia
4
Namibia
4
Eswatini/ Swaziland
4
Mozambique
3
Lesotho
3
Latin America and the Carribbean
3
Africa
3
Eastern Europe
3
Congo, Democratic Republic of
2
Haiti
2
Iraq
2
Germany
2
Lebanon
2
Cambodia
2
China
2
Benin
2
Botswana
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Laos
2
Jamaica
2
Guinea
1
USA
1
Cameroon
1
Philippines
1
Pakistan
1
South Sudan
1
Jordan
1
Afghanistan
1
Thailand
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Serbia
1
Colombia
1
Bolivia
1
Sri Lanka
1
Chile
1
Yemen
1
East and Southern Africa
1
Asia
1
Bhutan
1
Poland
1
North Korea
1
Albania
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
207
Clinical Guidelines
35
Public Health
24
Key Resources
11
Pharmacy & Technologies
11
Women & Child Health
5
Toolboxes
AMR
58
HIV
32
Mental Health
30
Pharmacy
26
TB
23
COVID-19
19
Rapid Response
11
Ebola
7
Conflict
7
NCDs
7
Caregiver
5
Global Health Education
3
Planetary Health
3
NTDs
3
Natural Hazards
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Cholera
1
Zika
1
Social Ethics
1
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
A survey of prevention, testing and treatment policies and practices
Towards the Peoples Health Assembly Book - 1
Towards the Peoples Health Assembly Book -1
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati
...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of
...
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
